Skip to main content

Full text of "USPTO Patents Application 09848616"

See other formats


In re application of: 



SEBBEL et al 



IN THE UNITED STATES PATENT AND TRADEMARK OFFICE 



Confirmation No.: 6018 



Art Unit: 1648 



Appl. No. 09/848,616 
Filed: May 4, 2001 



Examiner: Mosher, M. 



Atty. Docket: 1 700.0 1 80002/JAG/B JD 



For: Molecular Antigen Array 

Amendment and Reply Under 37 C.F.R. § 1.111 



Mail Stop RCE 

Commissioner for Patents 

P.O. Box 1450 

Alexandria, VA 22313-1450 



Filed concurrently herewith is a Request for Continued Examination (RCE) under 
37 C.F.R. § 1.114 in the above-captioned application. Therefore, in reply to the Office 
Action dated October 3 1 , 2003, Applicants submit the following Amendment and Remarks. 
It is respectfully believed that entry and consideration of these amendments and remarks is 
proper under 37 C.F.R. § 1.1 14, as this submission is being filed prior to payment of the 
issue fee, abandonment of the application, or filing of a Notice of Appeal to the U.S. Court 
of Appeals of the Federal Circuit. In accordance with 37 C.F.R. § 1.121, this Amendment is 
provided in the following format: 

(A) Each section begins on a separate sheet; 

(B) Starting on a separate sheet, a complete listing of all the claims: 

in ascending order; 

with status identifiers; and 

with markings in the currently amended claims; and 

(C) Starting on a separate sheet, the Remarks. 



Sir: 



- 2 - SEBBEL et al 

Appl. No. 09/848,616 

It is not believed that extensions of time or fees for net addition of claims are required 
beyond those that may otherwise be provided for in documents accompanying this paper. 
However, if additional extensions of time are necessary to prevent abandonment of this 
application, then such extensions of time are hereby petitioned under 37 C.F.R. § 1.136(a), 
and any fees required therefor (including fees for net addition of claims) are hereby 
authorized to be charged to our Deposit Account No. 19-0036.